Neurologists need to understand the phenomenon of using psychedelic drugs for cluster-busting and advocate for appropriate research.
Diana M. Rojas-Soto, MD
Mood disorders are significant comorbidities and frequently undertreated, despite growing evidence of benefits of treatment.
Lindsay M. Higdon, MD
A newly recognized category of epilepsy caused by or associated with antibodies.
Daniel Kantor, MD, FAAN, FANA
What is the value of neuropsychologic testing for patients with MS when there are often no available treatments?
Joon Y. Kang, MD
Neurosurgical techniques are effective and underutilized for patients with drug-resistant epilepsy.